Clinical trial
A Pilot Study; a Randomized Double-blind Placebo-controlled Study to Investigate a Probiotic Supplement on Symptoms of Upper Respiratory Tract Infections
NCT07835100 is registered in ClinicalTrials.gov with BioGaia AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study; a Randomized Double-blind Placebo-controlled Study to Investigate a Probiotic Supplement on Symptoms of Upper Respiratory Tract Infections
- Lead sponsor
- BioGaia AB
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 25, 2026
- Completion date
- April 30, 2028
- Enrollment
- 70 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
upper respiratory tract infection (urti)